UPDATE
: Monday, September 7, 2020
Home
Login
Mobile Version
All
Hospital
Pharma
Bio
Korea‘s Bio Industry
Device/ICT
Policy
People
Life science
Special
Innovation for Survival
Korea’s medical culture series
Korea’s New Candidate Drug Watch List
Special Series in Celebration of KBR's 1st Anniversary
Interview with foreign envoys
Special Series in Celebration of KBR’s 2nd Anniversary
Interview with global pharma
Special Series in Celebration of KBR’s 3rd Anniversary
Special Series in Celebration of KBR’s 4th Anniversary
ASCO 2020 Highlights
Opinion
Reporter’s Notebook
Search
트위터
페이스북
RSS
상단여백
제목보기
제목보기
제목+내용
Smiths Medical sees growth potential in Korea
Smiths Medical, a U.S. supplier of therapeutic devices for respiratory care...
by Park Gi-taek
|
2020-08-18 15:41
라인
Curocell draws $37-million investment, steps up trials of CAR-T therapy
Curocell, Korea’s first developer of chimeric antigen receptor T (CAR-T) ce...
by Park Gi-taek
|
2020-08-10 17:28
라인
‘TAVI procedures should be customized for heart patients’
“From now on, Korean hospitals should provide Transcatheter Aortic Valve Im...
by Park Gi-taek
|
2020-07-22 10:33
라인
Myongji Hospital opens brain tissue bank
Myongji Hospital has launched a brain tissue bank without any state funding...
by Park Gi-taek
|
2020-07-14 13:54
라인
Celltrion tops pharmaceutical brand reputation in June
Celltrion ranked the first in the local brand reputation of listed pharmace...
by Park Gi-taek
|
2020-06-26 15:23
라인
‘Blood test can detect Alzheimer’s early’
Local researchers said they have clinically proven how to diagnose Alzheime...
by Park Gi-taek
|
2020-06-04 15:40
라인
'Lazertinib showed effect on lung cancer, brain metastasis'
Yuhan Corp. said its investigational anticancer drug Lazertinib has proved ...
by Park Gi-taek
|
2020-06-01 14:08
라인
Il-yang wins Russia’s nod to test potential Covid-19 drug in phase-3 study
Il-yang Pharmaceutical said it has obtained Russian approval to evaluate it...
by Park Gi-taek
|
2020-05-29 16:57
라인
‘Canon Medical will be game-changer in medical imaging market’
“It is true Canon Medical Systems is a latecomer in the local medical imagi...
by Park Gi-taek
|
2020-05-28 16:24
라인
JW Pharm to suffer most from suspended sale of 31 diabetes drugs
The regulator has suspended the sales of 31 metformin-containing diabetes d...
by Park Gi-taek
|
2020-05-27 11:26
라인
‘NECA’s role to grow bigger, more important’
“Now is the time to reaffirm the identity of the National Evidence-based He...
by Park Gi-taek
|
2020-05-20 16:17
라인
Government to reevaluate dementia drug choline alfoscerate
The Ministry of Health and Welfare said it would reassess whether choline a...
by Park Gi-taek
|
2020-05-18 14:58
라인
Korea upgrades guidelines for multidrug-resistant tuberculosis
Korean patients with multidrug-resistant tuberculosis (TB) will likely get ...
by Park Gi-taek
|
2020-05-13 16:47
라인
Mobile health app helped lose weight in antiobesity program
A mobile health care application used for an obesity treatment program, joi...
by Park Gi-taek
|
2020-04-29 14:59
라인
Multidisciplinary cure is mainstream cancer treatment but cumbersome
“Cancer” is the area where multidisciplinary treatments are being made most...
by Park Gi-taek
|
2020-04-21 17:09
라인
Demands for Korean testing kits soar amid COVID-19 pandemic
With China-originated new coronavirus (COVID-19) sweeping the entire globe,...
by Park Gi-taek
|
2020-03-17 14:25
라인
Three-quarters of healthcare workers suffer from infection fears
About three out of four hospital employees, including doctors and nurses, a...
by Park Gi-taek
|
2020-03-16 16:59
라인
‘COVID-19 occurring in 102 countries signals a pandemic’
The confirmed cases of the new coronavirus (COVID-19) have spanned more tha...
by Park Gi-taek
|
2020-03-09 15:12
라인
Korean drugmakers step up developing COVID-19 vaccine, treatments
Fifteen Korean pharmaceutical and biotech companies have jumped into the de...
by Park Gi-taek
|
2020-03-09 15:11
라인
Seoul's anti-epidemic steps do not hinder business, European chamber says
A majority of European companies operating in Korea said they experienced s...
by Park Gi-taek
|
2020-03-05 15:43
-
1
2
3
4
5
6
7
-
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
여백
Most viewed
1
‘Cyramza helped improve gastric cancer treatment in Korea’
2
‘Reduced-dose prasugrel effective for ACS patients undergoing PCI’
3
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
4
SNUBH develops AI model predicting patients at risk of cerebral aneurysm
5
Novavax releases encouraging phase-1 results on Covid-19 vaccine candidate
6
LG Chem, SK Bioscience end sales partnership with Daewoong
7
UBcare wins patent for tech to monitor suspected infectious diseases
8
176 civic groups furious over government-doctors deal
9
Recovered Covid-19 patients suffer from aftereffects – for long
10
Regulator OKs JW Pharma's rheumarthritis drug for treating giant cell arteries
여백
Opinion
[Column] Correct diagnosis leads to proper treatment
[Column] How ongoing doctors’ strike is different from 20 years ago
A Korean-American Doctor asks: Is Korea truly in 2020?
여백
Back to Top